1. Report Introduction
2. Chemotherapy Induced Nausea and Vomiting Epidemiology Overview at a Glance
3. Market Share Distribution of Chemotherapy Induced Nausea and Vomiting
4. Disease Background and Overview: Chemotherapy Induced Nausea and Vomiting
4.1. Introduction
4.2. Signs and Symptoms
4.3. Etiology
4.4. Risk Factors
4.5. Pathophysiology
4.6. Diagnostic Landscape
4.6.1. Diagnostic Practices
4.6.2. Diagnostic Criteria
4.6.3. Diagnostic Recommendations
4.7. Treatment Landscape
4.7.1. Current Treatment Practices
4.7.2. Treatment Algorithm
4.7.3. Treatment Recommendations
5. Chemotherapy Induced Nausea and Vomiting Epidemiology
5.1. Key Findings
5.2. Assumptions & Rationale
5.3. 7MM Epidemiology
6. Epidemiology of Chemotherapy Induced Nausea and Vomiting by Countries
7. United States
7.1. Assumptions and Rationale
7.2. Prevalent/Incident Cases of Chemotherapy Induced Nausea and Vomiting
7.3. Sub-Type Specific cases of Chemotherapy Induced Nausea and Vomiting*
7.4. Sex- Specific Cases of Chemotherapy Induced Nausea and Vomiting*
7.5. Diagnosed Cases of Chemotherapy Induced Nausea and Vomiting
7.6. Treated Cases of Chemotherapy Induced Nausea and Vomiting
8. EU5
8.1. Germany
8.1.1. Assumptions and Rationale
8.1.2. Prevalent/Incident Cases of Chemotherapy Induced Nausea and Vomiting
8.1.3. Sub-Type Specific cases of Chemotherapy Induced Nausea and Vomiting*
8.1.4. Sex- Specific Cases of Chemotherapy Induced Nausea and Vomiting*
8.1.5. Diagnosed Cases of Chemotherapy Induced Nausea and Vomiting
8.1.6. Treated Cases of Chemotherapy Induced Nausea and Vomiting
8.2. France
8.2.1. Assumptions and Rationale
8.2.2. Prevalent/Incident Cases of Chemotherapy Induced Nausea and Vomiting
8.2.3. Sub-Type Specific cases of Chemotherapy Induced Nausea and Vomiting*
8.2.4. Sex- Specific Cases of Chemotherapy Induced Nausea and Vomiting*
8.2.5. Diagnosed Cases of Chemotherapy Induced Nausea and Vomiting
8.2.6. Treated Cases of Chemotherapy Induced Nausea and Vomiting
8.3. United Kingdom
8.3.1. Assumptions and Rationale
8.3.2. Prevalent/Incident Cases of Chemotherapy Induced Nausea and Vomiting
8.3.3. Sub-Type Specific cases of Chemotherapy Induced Nausea and Vomiting*
8.3.4. Sex- Specific Cases of Chemotherapy Induced Nausea and Vomiting*
8.3.5. Diagnosed Cases of Chemotherapy Induced Nausea and Vomiting
8.3.6. Treated Cases of Chemotherapy Induced Nausea and Vomiting
8.4. Spain
8.4.1. Assumptions and Rationale
8.4.2. Prevalent/Incident Cases of Chemotherapy Induced Nausea and Vomiting
8.4.3. Sub-Type Specific cases of Chemotherapy Induced Nausea and Vomiting*
8.4.4. Sex- Specific Cases of Chemotherapy Induced Nausea and Vomiting*
8.4.5. Diagnosed Cases of Chemotherapy Induced Nausea and Vomiting
8.4.6. Treated Cases of Chemotherapy Induced Nausea and Vomiting
8.5. Italy
8.5.1. Assumptions and Rationale
8.5.2. Prevalent/Incident Cases of Chemotherapy Induced Nausea and Vomiting
8.5.3. Sub-Type Specific cases of Chemotherapy Induced Nausea and Vomiting*
8.5.4. Sex- Specific Cases of Chemotherapy Induced Nausea and Vomiting*
8.5.5. Diagnosed Cases of Chemotherapy Induced Nausea and Vomiting
8.5.6. Treated Cases of Chemotherapy Induced Nausea and Vomiting
9. Japan
9.1. Assumptions and Rationale
9.2. Prevalent/Incident Cases of Chemotherapy Induced Nausea and Vomiting
9.3. Sub-Type Specific cases of Chemotherapy Induced Nausea and Vomiting*
9.4. Sex- Specific Cases of Chemotherapy Induced Nausea and Vomiting*
9.5. Diagnosed Cases of Chemotherapy Induced Nausea and Vomiting
9.6. Treated Cases of Chemotherapy Induced Nausea and Vomiting
10. Unmet Needs
Appendix
Report Methodology
Sources Used
Disclaimer
About CmaxInsight
*Indication Specific

Note: Certain sections of the table of contents would vary according to the availability of information.